American Journal of Kidney Diseases
Volume 53, Issue 3, Supplement 3 , Pages S86-S99 , March 2009

Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente

  • Mark Rutkowski, MD

      Affiliations

    • Division of Nephrology, Baldwin Park Medical Center, Southern California Kaiser Permanente, Baldwin Park, CA
    • Corresponding Author InformationAddress correspondence to Mark Rutkowski, MD, 1011 Baldwin Park Blvd, Baldwin Park, CA 91706
    • ,
  • Wendy Mann, PharmD

      Affiliations

    • Pharmacy and Analytic Services, Southern California Kaiser Permanente, Downey, CA
    • ,
  • Stephen Derose, MD, MS

      Affiliations

    • Research and Evaluation, Southern California Kaiser Permanente, Pasadena, CA
    • ,
  • David Selevan, BS

      Affiliations

    • Renal Program Administration, Southern California Kaiser Permanente, Pasadena, CA
    • ,
  • Noel Pascual, HS

      Affiliations

    • Renal Program Administration, Southern California Kaiser Permanente, Pasadena, CA
    • ,
  • Jean Diesto, RN, BSN

      Affiliations

    • Renal Program Administration, Southern California Kaiser Permanente, Pasadena, CA
    • ,
  • Peter Crooks, MD

      Affiliations

    • Renal Program Administration, Southern California Kaiser Permanente, Pasadena, CA

References 

  1. Kidney Disease Outcomes Quality Initiative (K/DOQI). Executive summary. Am J Kidney Dis. 2002;39(suppl 1):S17–S31
  2. Stevens LA, Levey AS. Current status and future perspectives for CKD testing. Am J Kidney Dis. 2009;53(suppl 3):S17–S26
  3. Kubasik NP, Lisuzzo CW, Same DG, Sine DG, D Souza JP. Multilayered film analysis: Evaluation of ammonia and creatinine slides. Clin Biochem. 1984;17:15–18
  4. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephol. 2000;11:155A;(abstr)
  5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  6. Rutkowski MP, Mann W, Araki DS, et al. Southern California Permanente Medical Group Algorithm to improve stability of chronic kidney disease restaging. J Am Soc Nephrol. 2002;13:264A;(abstr F-P0996)
  7. National Kidney Foundation. K/DOQI guidelines (Definition and classification of stages of kidney disease). Am J Kidney Dis. 2002;39(suppl 1):S46–S64
  8. Jones CA, Francis ME, Eberhardt MS, et al: Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 39:445-459
  9. Watkin DM, Shock NW. Agewise standard value for CIN, CPAH, and TmPAH in adult males. J Clin Invest. 1955;34:969;(abstr)
  10. Cooperative Healthcare Reporting Initiative Report on Quality. http://www.cchri.org/reports2007;Accessed March 1, 2008
  11. Derose SF, Dudl JR, Benson VM, Contreras R, Nakahiro RK, Ziel FH. Point-of-service reminders for prescribing cardiovascular medications. Am J Manag Care. 2005;11:298–304
  12. Glazer S, Diesto J, Crooks P, et al. Going beyond the Kidney Disease Outcomes Quality Initiative: Hemodialysis access experience at Kaiser Permanente Southern California. Ann Vasc Surg. 2006;20:75–82
  13. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int. 2002;61:305–316

PII: S0272-6386(08)01729-0

doi: 10.1053/j.ajkd.2008.07.052

American Journal of Kidney Diseases
Volume 53, Issue 3, Supplement 3 , Pages S86-S99 , March 2009

Article Tools

* Image Usage & Resolution